Free Trial

7 Hotel Stocks Just Waiting For the Vaccine - 5 of 7

 
 

#5 - Wyndham Hotels & Resorts (NYSE:WH)

Being the largest may have its advantages. At least that seems to be the case for Wyndham Hotels & Resorts (NYSE:WH). The company recently posted its fourth-quarter earnings and came in with full-year revenue of $1.3 billion which was about 35% lower than the $2.05 billion it recorded in 2019.

Still that’s a less bad number that investors can work with. And the company recorded a beat on both the top and bottom lines. That made it three out of four quarters in which the company topped analysts’ estimates.

Wyndham has over 9,000 locations worldwide and includes some of the best-known value chains such as Super 8, Ramada, Days Inn, and Howard Johnson.

Wyndham’s stock price has recently made it back to pre-pandemic levels and analysts are giving the stock a consensus rating of buy. The stock remains about 10% shy of when it went public in 2018. But the company has an impressive market cap that currently sits at around $5.6 billion.

About Wyndham Hotels & Resorts

Wyndham Hotels & Resorts, Inc engages in the franchise and operation of hotels under the Wyndham brand. It operates through the following segments: Hotel Franchising, Hotel Management, and Corporate and Other. The Hotel Franchising segment focuses on licensing the company's lodging brands and providing related services to third-party hotel owners and others. More
Current Price
$106.08
Consensus Rating
Moderate Buy
Ratings Breakdown
9 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$108.10 (1.9% Upside)